Saturday, October 17, 2026 · Edition updated 6:00 AM ETSAT, OCT 17 · 6 AM ET editionNext edition in Next --:--:--

A new study will look at reading loss after stroke and reading in older adults

Recruiting · Georgetown University

What this means

Researchers plan to test reading, speech, language, and thinking in stroke survivors and typical older adults, with some brain scans. This is a trial that has not reported results, so it does not yet show what they will find.

Plain-English summary written by an AI model from the registry listing.

Status
Recruiting
Who can join
Ages 18 and over
Where
1 site, including District of Columbia

Contacts and how to join ↗

The science

Registered title
ReadMap: Reading in Stroke Alexia and Typical Aging
Phase
Not applicable
Study type
observational
Conditions
Aphasia, Stroke, Alexia
Sponsor
Georgetown University
Ages
18 Years to no maximum
Dates
First posted Nov 21, 2024 · updated Nov 21, 2024

Registry summary

Loss of reading ability due to stroke, called alexia, likely affects over a million Americans at any given time and causes difficulty performing many daily life functions, such as paying bills, using email/text, reading for pleasure, and reading signs in the community. Understanding the brain and cognitive basis of alexia could improve diagnosis and treatment of this important problem. In this study, the investigators will perform a large-scale behavioral and brain imaging study of stroke survivors and typical older adults to improve our understanding of the brain and cognitive basis of reading in both of these groups.

Participants will complete a battery of tests of reading, speech, language, and thinking abilities. In addition, some participants will complete an MRI. Sessions will be completed across approximately 2-6 weeks, but may be extended depending on participants' schedules and availability. Some participants will be invited to repeat these procedures once or twice in approximately 3-12 months to monitor for changes in reading abilities and MRI measurements over time.

Sites (1)

  • Georgetown University Medical Center, Washington D.C., District of Columbia, United States

More aging trials in these states

District of Columbia

Report a problem